Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S-1 monotherapy in patients with advanced biliary tract cancer.
Sasaki T, Isayama H, Yashima Y, Yagioka H, Kogure H, Arizumi T, Togawa O, Matsubara S, Ito Y, Nakai Y, Sasahira N, Hirano K, Tsujino T, Tada M, Kawabe T, Omata M. Sasaki T, et al. Among authors: hirano k. Oncology. 2009;77(1):71-4. doi: 10.1159/000226214. Epub 2009 Jun 26. Oncology. 2009. PMID: 19556812
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.
Sasaki T, Isayama H, Nakai Y, Ito Y, Kogure H, Togawa O, Toda N, Yasuda I, Hasebe O, Maetani I, Sasahira N, Hirano K, Tsujino T, Tada M, Omata M. Sasaki T, et al. Among authors: hirano k. Cancer Chemother Pharmacol. 2010 May;65(6):1101-7. doi: 10.1007/s00280-009-1115-5. Epub 2009 Aug 26. Cancer Chemother Pharmacol. 2010. PMID: 19707761 Clinical Trial.
A pilot study for combination chemotherapy using gemcitabine and S-1 for advanced pancreatic cancer.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Ito Y, Kogure H, Togawa O, Matsubara S, Arizumi T, Yagioka H, Yashima Y, Kawakubo K, Mizuno S, Yamamoto K, Hirano K, Tsujino T, Ijichi H, Toda N, Tada M, Kawabe T, Omata M. Nakai Y, et al. Among authors: hirano k. Oncology. 2009;77(5):300-3. doi: 10.1159/000259616. Epub 2009 Nov 17. Oncology. 2009. PMID: 19923869
Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Kogure H, Hirano K, Tsujino T, Ijichi H, Tateishi K, Tada M, Omata M, Koike K. Nakai Y, et al. Among authors: hirano k. Jpn J Clin Oncol. 2010 Aug;40(8):774-80. doi: 10.1093/jjco/hyq059. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462979 Clinical Trial.
Impact of S-1 on the survival of patients with advanced pancreatic cancer.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Ito Y, Kogure H, Togawa O, Matsubara S, Arizumi T, Yagioka H, Yashima Y, Kawakubo K, Mizuno S, Yamamoto K, Hirano K, Tsujino T, Ijichi H, Tateishi K, Toda N, Tada M, Omata M, Koike K. Nakai Y, et al. Among authors: hirano k. Pancreas. 2010 Oct;39(7):989-93. doi: 10.1097/MPA.0b013e3181d91936. Pancreas. 2010. PMID: 20467352
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
Sasaki T, Isayama H, Nakai Y, Togawa O, Kogure H, Ito Y, Yamamoto K, Mizuno S, Yagioka H, Yashima Y, Kawakubo K, Arizumi T, Matsubara S, Sasahira N, Hirano K, Tsujino T, Toda N, Tada M, Omata M, Koike K. Sasaki T, et al. Among authors: hirano k. Cancer Chemother Pharmacol. 2011 Apr;67(4):847-53. doi: 10.1007/s00280-010-1360-7. Epub 2010 Jun 20. Cancer Chemother Pharmacol. 2011. PMID: 20563811
Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy.
Nakai Y, Isayama H, Sasaki T, Sasahira N, Tsujino T, Kogure H, Yagioka H, Yashima Y, Togawa O, Arizumi T, Matsubara S, Hirano K, Tada M, Omata M, Koike K. Nakai Y, et al. Among authors: hirano k. Crit Rev Oncol Hematol. 2011 Jun;78(3):252-9. doi: 10.1016/j.critrevonc.2010.05.007. Epub 2010 Jun 25. Crit Rev Oncol Hematol. 2011. PMID: 20579902
2,431 results